The ORBITAL Project focuses on developing innovative technologies to treat diseases of the back of the eye, such as diabetic eye disease and age-related macular degeneration (AMD), which are some of the main causes of blindness and severe vision impairment in elderly patients in Europe.

About Orbital ITN

The ORBITAL (Ocular Research By Integrated Training And Learning) network is an EU-funded Marie Sklodowska-Curie Innovation Training Network (MSCA-ITN). This ITN will train 15 early stage researchers (PhD students) across Europe to develop drug delivery technologies that can help treat posterior segment diseases of the eye, e.g. age-related macular degeneration and diabetic retinopathy. In so doing, ORBITAL aims to improve the quality of life and clinical outcomes for patients with these conditions.

The network is built on an intersectoral and broadly international consortium (academia, industry, clinicians, patient advocacy groups and hospitals) composed of members from Europe, Canada and the US. The goal is to train researchers to PhD level, ensuring that they have a clear focus on patient needs and interdisciplinary skills. We will have a strong focus on outreach, dissemination, patient and public engagement.


John Leonard

Life with AMD

John had never heard of age-related macular degeneration (AMD) until he accidentally came across the term and its home test, the Amsler Grid. His sight had deteriorated rapidly over the previous 12 months and when he looked at the grid, the lines were wavy, when they should have been straight.

Diagnosed with wet AMD, John takes special eye health supplements and gets regular injections into his left eye. They maintain the bit of eye sight John has left.

John admits he used to get very frustrated with his sight loss, but has adapted to his new reality. A magnifying glass with a light is a huge help, as is a key ring that tells him the time. John regularly advocates for people living with sight loss and is passionate about research into treatments and cures for AMD.

We have a podcast!

Listen to our channel to stay up-to-date on the latest in breakthroughs and technological advances in Ocular Drug Delivery Technology.



Contact Us

Dr. Laurence Fitzhenry ORBITAL Project Coordinator If you have any questions, please do not hesitate to contact us.

This project is funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Actions (grant agreement – No 813440)